Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1998-6-23
|
pubmed:abstractText |
Ropivacaine, a new local anaesthetic agent, has been demonstrated to have less potential than bupivacaine for central nervous system toxicity on the basis of human and animal studies. We report a case of a convulsion secondary to presumed inadvertent intravascular injection of 20 mg of ropivacaine in a 44 kg patient during an epidural for chronic pain. There were minimal signs of cardiovascular toxicity.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0310-057X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
204-6
|
pubmed:dateRevised |
2006-8-28
|
pubmed:meshHeading |
pubmed-meshheading:9564403-Adolescent,
pubmed-meshheading:9564403-Amides,
pubmed-meshheading:9564403-Anesthetics, Local,
pubmed-meshheading:9564403-Humans,
pubmed-meshheading:9564403-Injections, Epidural,
pubmed-meshheading:9564403-Male,
pubmed-meshheading:9564403-Pain, Intractable,
pubmed-meshheading:9564403-Seizures
|
pubmed:year |
1998
|
pubmed:articleTitle |
Central nervous system toxicity attributable to epidural ropivacaine hydrochloride.
|
pubmed:affiliation |
Department of Anaesthesia, Geelong Hospital, Geelong.
|
pubmed:publicationType |
Journal Article,
Case Reports
|